Octreotide in the treatment of refractory ascites of cirrhosis [1]

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 6, 2006, Pages 763-

  Leong, Rupert ^a   Jeffrey, Gary ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ASCITES; CASE REPORT; CHYLOUS ASCITES; DOSE TIME EFFECT RELATION; FEMALE; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CIRRHOSIS; PARACENTESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; THORACOCENTESIS; TREATMENT OUTCOME;

ADULT; ASCITES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; LIVER CIRRHOSIS; OCTREOTIDE; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 33745686087     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600648055     Document Type: Letter

References (2)

1. Kalambokis G, Fotopoulos A, Economou M, Tsianos EV. Octreotide in the treatment of refractory ascites of cirrhosis. Scand J Gastroenterol 2006;41:118-21.
2. Leong RW, House AK, Jeffrey GP. Chylous ascites caused by portal vein thrombosis treated with octreotide. J Gastroenterol Hepatol 2003;18:1211-3.